She points out that some of the weight lost on Ozempic, Wegovy or Mounjaro can be muscle, and argues this matters more in midlife. It's general advice, not new research.
Recap by typeshit. Post by @itssosimple_rs on Instagram.
Both suppliers of compounded semaglutide and tirzepatide ingredients landed on the FDA import-alert list. Times Now also covers dosing mistakes with compounded vials.
Penn researchers stress the self-reports in JAMA Network Open don't prove the drug caused anything, but increased appetite topped the list despite trials pointing to nausea.
The visits came in the country's largest healthcare system, with the trend credited to wellness influencers and young people among those affected.
Researchers at the American Academy of Ophthalmology meeting found NAION patients on GLP-1 drugs tended to develop it in the other eye sooner.
Researchers found 39% of GLP-1 users reported nail detachment, compared with 9% of non-users. The authors stress the data is self-reported and doesn't prove the drugs cause it.
An opinion piece drawing on Sabrina Strings to tie GLP-1 culture, celebrity ads and Ozempic-friendly menus to class and belonging.
Loading…